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Abstract
Insulin-like growth factors (IGFs) are mediators of growth hormones; they have an influence on cell proliferation and
differentiation. In addition, IGF-binding protein (IGFBP)-3 could suppress the mitogenic action of IGFs. Interestingly, tea
polyphenols could substantially reduce IGF1 and increase IGFBP3. In this study, we evaluated the effects of smoking, green
tea consumption, as well as IGF1, IGF2, and IGFBP3 polymorphisms, on lung cancer risk. Questionnaires were administered to
obtain the subjects’ characteristics, including smoking habits and green tea consumption from 170 primary lung cancer
cases and 340 healthy controls. Genotypes for IGF1, IGF2, and IGFBP3 were identified by polymerase chain reaction. Lung
cancer cases had a higher proportion of smoking, green tea consumption of less than one cup per day, exposure to cooking
fumes, and family history of lung cancer than controls. After adjusting the confounding effect, an elevated risk was observed
in smokers who never drank green tea, as compared to smokers who drank green tea more than one cup per day (odds
ratio (OR)=13.16, 95% confidence interval (CI)=2.96–58.51). Interaction between smoking and green tea consumption on
lung cancer risk was also observed. Among green tea drinkers who drank more than one cup per day, IGF1 (CA)19/(CA)19 and
(CA)19/X genotypes carriers had a significantly reduced risk of lung cancer (OR=0.06, 95% CI=0.01–0.44) compared with
IGF1 X/X carriers. Smoking-induced pulmonary carcinogenesis could be modulated by green tea consumption and their
growth factor environment.
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Introduction
Lung cancer is the most frequently occurring cancer worldwide
[1], and it has a well established correlation with cigarette smoking
[2]. Free radicals have been also implicated in smoking-related
carcinogenesis [3,4]. Thus, an oxidant/antioxidant imbalance
may play a role in lung carcinogenesis among those exposed to
cigarette smoke.
Tea is consumed largely in Asian countries, such as Japan,
China and Taiwan [5]. Tea has received a great deal of attention
because tea polyphenols are strong antioxidants. Experimental
studies have shown consistently that green tea may inhibit the
induction of a number of cancers [6,7]. However, the mechanisms
of these inhibitory effects are not clear, and epidemiological studies
of tea consumption and cancer are limited and results are
inconclusive [8–10].
Insulin-like growth factors (IGFs), IGF1 and IGF2 are peptide
hormones with strong mitogenic effect on both normal and
cancerous cells, including lung cancer [11,12]. Their major
binding protein, IGF-binding protein 3 (IGFBP3), not only
regulates the mitogenic action of IGFs but also inhibits their
antiapoptotic effect [11]. Besides its IGF-dependent function,
IGFBP3 also has an IGF independent inhibitory effect on cell
growth [11]. The level of IGFBP3 in serum, in some situations,
suppresses the mitogenic action of IGFs, and is inversely associated
with cancer risk [13]. Previous studies of the relationship of
smoking and IGFs levels, however, have yielded inconsistent
results [14,15]. In addition, tea polyphenols are associated with a
substantial reduction in IGF1 levels and an increase in IGFBP3
levels in TRAMP mice [16] as well as human colon cell lines [17].
Therefore, tea polyphenols may decrease lung cancer risk by
increasing IGFBP3 levels and lowering IGFs.
Rosen et al. [18] first reported that the (CA)19/(CA)19 genotype
for the IGF1 microsatellite polymorphism (cytosine-adenosine, or
CA dinucleotide repeat) was associated with decreased levels of
serum IGF1. In addition, a cohort study of over 2,500 Caucasian
males established a relationship between an ApaI polymorphism
(rs680) in the IGF2 gene region of chromosome 11p15 and serum
IGF2 concentrations [19]. Deal et al. [20] also indicated that
several single-nucleotide polymorphisms in the promoter of
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7IGFBP3, and documented in vitro significantly higher promoter
activity of the A allele at the -202 locus (rs2854744) compared with
the C allele, consistent with the relationship observed between
genotype and circulating IGFBP3.
Here, we evaluated the effects of smoking, green tea
consumption, and IGF1, IGF2, and IGFBP3 genotypes on lung
cancer risk. We also assessed the joint effects of smoking and green
tea consumption, and smoking and IGFs and IGFBP3 genotypes on
lung cancer risk. Then, we examined the effect of IGFs and
IGFBP3 on lung cancer stratified by habits of green tea
consumption.
Materials and Methods
Study design
Our entire study in which experiments on patients or healthy
volunteers, patient’s case histories conformed to the Declaration of
Helsinki, and their consent statement was written. The design of
the work and final report were approved by the institutional
review board of participating institutions.
From August 2004 to October 2008, a total of 241 lung cancer
patients (International Classification of Diseases, 9th revision; ICD
code 162) were recruited from Changhwa Christian Hospital
(Changhwa County, Taiwan). The hospital was accessible to
patients from all socioeconomic classes. All patients underwent a
series of examinations of pathologic stages by board-certified
pathologists. Tumor types and stages were determined according
to the World Health Organization classification [21]. Ten patients
were not interviewed because of severe illness, 37 were not
interviewed because they were not the incident cases, and 24 were
excluded due to older age (range=80–92 years) or incomplete or
missing questionnaire data. Among 170 patients available for
matching, cell types included 93 adenocarcinoma (54.7%), 46
squamous cell carcinoma (27.1%), and 31 others (including small
cell carcinoma, neuroendocrine carcinoma, mixed cell carcinoma,
and unspecific malignant cell). For this case-control study, two
controls were selected for each lung cancer case, matched by
gender and age (65 years). Therefore, 340 controls were randomly
selected from consecutive patients with no history of cancer who
were admitted to the same teaching medical center for physical
check-up.
Epidemiological information
Epidemiological information was collected from study subjects
by in-person interviews using a standardized questionnaire. The
questionnaire contained questions involving demographic charac-
teristic and lifestyle. Subjects’ smoking habits included the number
of cigarettes smoked daily and the length of time smoking. The
parameter ‘‘pack-years’’ were used to indicate cumulative smoking
dose, defined as the number of packs of cigarettes smoked daily
multiplied by the number of years of active smoking. In Taiwan,
tea is the most commonly made in a small earthenware teapot.
Tea is served in small cups (30–50 ml), and the same tea leaf can
be brewed many times. In this study, we defined a standardized
cup of tea as 100–120 ml. The period of exposure was assessed
from birth to the day when lung cancer was first diagnosed (for
cases) or when the interview was performed (for controls). To
prevent misclassification of tea intake for individuals who changed
their tea consumption after diagnosis, we collected only cumulative
amounts before disease onset. Subjects who reported drinking
green tea were further asked the length (number of years) and
frequency of green tea consumption: every day ($1 cup per day),
3–4 cups per week, 1–2 cups per week, 1–2 cups per month and
seldom. Those who consumed tea every day were asked the
number of cups drunk: ,1, 1–2, 3–4, 5–9, or 10+ per day, based
on a previous study [10]. Intake of fruits and vegetables was
measured as the average number of standardized servings per
week of fruits and vegetables over the last 3 years. For cooking
exposures, subjects were asked the frequency of using various
cooking methods, such as stir-frying. Family history of lung cancer
was defined as lung cancer in first-degree relatives of the test
subject.
Genotyping analysis of IGF1, IGF2, and IGFBP3
Venous blood was collected into heparinized tubes from all
subjects, and was prepared into plasma, buffy coat and red blood
cells. Genomic DNA was extracted from buffy coat. Genotype was
analyzed using polymerase chain reaction (PCR)-based methods as
described below. The IGF1 (CA)n repeat was determined by PCR
amplification of the polymorphic region as described by Rosen
et al. [18]. A microsatellite located in the promoter of the IGF1
gene was used to type the IGF1 gene. Primers used to amplify the
IGF1 gene were 59-GCT AGC CAG CTG GTG TTA TT-39 and
59-ACC ACT CTG GGA GAA GGG TA-3; the forward primer
was labeled with a fluorescent dye (FAM). One half microliter of
DNA was added to a PCR buffer containing 200 ng of primers,
1.5 mM MgCl2, 0.2 mM of dNTPs, 50 mM KCl, 10 mM Tris-
HCl (pH 8.3), and 0.1% of bovine serum albumin in a final
volume of 50 ml. The cycling parameters consisted of an initial
incubation of 5 min at 94uC, followed by 35 cycles of 1 min at
94uC (denaturing step), 1 min at 57uC (annealing), and 1 min at
72uC (extension). The lengths of fragments were assigned by short
tandem repeat polymorphism using the ABI 3730 DNA sequencer
and Genemapper Software (Applied Biosystems, Foster City, CA,
USA). This genotyping was done by the National Genotyping
Center, Institute of Biomedical Sciences, Academia Sinica (Taipei,
Taiwan). Furthermore, representative homozygotes were se-
quenced to confirm (CA)n repeat numbers from base pair lengths,
using ABI 3730 DNA sequencer and Chromas Lite 2.0 for
Windows Software (Technelysium Pty Ltd, Eden Prairie, MN,
USA).
For IGF2 gene analysis, restriction fragment length polymor-
phism (RFLP) was detected by differences in ApaI at 820 locus
(rs680) of IGF2 following PCR amplification [22]. Primers used to
amplify the IGF2 gene were 59-GCA CAG CAG CAT CTT CAA
ACA TG-39 and 59-GGG TCG TGC CAA TTA CAT TTC AT-
39. The cycling parameters consisted of an initial incubation of
5 min at 94uC, followed by 35 cycles of 30 s at 94uC, 30 s at 65uC,
and 1 min at 72uC. The PCR products were digested with ApaI.
Homozygous AA individuals exhibited a product fragment of
620 bp, homozygous GG individuals had a 390 bp and 230 bp
fragment, and heterozygous AG individuals had all three
fragments. The IGFBP3 FspI polymorphism (rs2854744) was
determined by the methods developed by Ren et al. [23]. Primers
used to amplify the IGFBP3 gene were 59-GAA TGC GGA GCG
CTG TAT G-39 and 59-TGT GGA ATC CAG GCA GGA AG-
39. The cycling parameters consisted of an initial incubation of
4 min at 94uC, followed by 35 cycles of 1 min at 94uC, 1 min at
65uC, and 1 min at 72uC. The PCR products were digested with
FspI. Homozygous AA individuals exhibited a product fragment of
483 bp, homozygous CC individuals had a 258 bp and 225 bp
fragment, and heterozygous AC individuals had all three
fragments.
Statistical analysis
Comparisons between case and control groups for gender, age,
smoking status, pack-years of smoking, green tea consumption,
dietary intake of fruits and vegetables, exposure to cooking fumes,
Green Tea, IGFs Genotypes and Lung Cancer Risk
PLoS ONE | www.plosone.org 2 February 2012 | Volume 7 | Issue 2 | e30951and family history of lung cancer were made using Student’s t-test
for continuous variables and x
2 test or Fisher’s exact test for
discrete variables. x
2 test was also used to test the prevalence of
IGF1 (CA)n repeat, IGF2 820 and IGFBP3 -202 genotypes between
case and control groups. A conditional logistic regression model
was employed to obtain the adjusted odds ratio (OR) and 95%
confidence interval (CI) for each variable. Likelihood ratio x
2 tests
were also utilized to test the interaction between smoking and
green tea consumption, and the interaction between smoking and
IGFs and IGFBP3 genotypes with respect to the risk of lung cancer.
Associations between lung cancer and IGFs and IGFBP3 genotypes
stratified by amount of green tea consumed were also assessed. A P
value ,0.05 was considered to indicate statistical significance, and
all tests were two-tailed. The type Ierror rate were adjusted by
multiple testing (bonferroni correction). All data were analyzed
using SAS 9.1 (SAS, Inc., Cary, NC, USA).
Results
The specific characteristics of study subjects were summarized
in Table 1. In total, 510 study subjects (306 males and 204 females)
participated in this study. Mean age was 66.2 years for lung cancer
patients (range=38–90 years) and 64.6 years for control subjects
(range=38–87 years) at recruitment. More smokers were
represented in the lung cancer cases compared with the controls
(54.1% versus 27.1%; P,0.01), 37.6% of smokers with lung
cancer smoked more than 40 pack-years, but only 14.7% of
controls who smoked. Besides, the groups were significantly
Table 1. Frequency distribution of specific characteristics by case and control status.
Variable Cases Controls OR (95% CI) P-value
1
(n=170) (n=340)
Gender
Male 102 (60.0%) 204 (60.0%) 1.00 (ref.) 1.00
Female 68 (40.0%) 136 (40.0%) 1.00 (0.69–1.46)
Age at recruitment (years ± SD) 66.2610.6 64.6610.6 0.12
#50 16 (9.4%) 34 (10.0%) 1.00 (ref.) 0.59
51–59 29 (17.1%) 70 (20.6%) 0.88 (0.42–1.84)
$60 125 (73.5%) 236 (69.4%) 1.13 (0.60–2.12)
Smoking status
Never smokers 78 (45.9%) 248 (72.9%) 1.00 (ref.) ,0.01
Current and ever smokers 92 (54.1%) 92 (27.1%) 7.61 (3.98–14.56)
Pack-years smoked
0 78 (45.9%) 248 (72.9%) 1.00 (ref.) ,0.01
1–39 28 (16.5%) 42 (12.4%) 4.79 (2.25–10.21)
$40 64 (37.6%) 50 (14.7%) 10.37 (5.07–21.24)
Green tea consumption (cups/day)
$1 7 (4.1%) 64 (18.8%) 1.00 (ref.) ,0.01
,1 18 (10.6%) 50 (14.7%) 3.01 (1.13–8.05)
0 145 (85.3%) 226 (66.5%) 6.34 (2.69–14.91)
Green tea consumption (years)
.10 9 (5.3%) 56 (16.5%) 1.00 (ref.) ,0.01
#10 16 (9.4%) 58 (17.1%) 1.90 (0.77–4.70)
0 145 (85.3%) 226 (66.5%) 4.96 (2.22–11.04)
Vegetables and fruits intakes (servings/week)
$21 86 (50.6%) 175 (51.5%) 1.00 (ref.) 0.36
15–20 42 (24.7%) 67 (19.7%) 1.28 (0.55–1.37)
#14 42 (24.7%) 98 (28.8%) 0.87 (0.79–2.06)
Exposure to fume of cooking (hours/week)
,1 135 (79.4%) 312 (91.8%) 1.00 (ref.) ,0.01
1–3 17 (10.0%) 16 (4.7%) 2.89 (1.33–6.29)
$3 18 (10.6%) 12 (3.5%) 3.80 (1.72–8.38)
Family history of lung cancer
No 160 (94.1%) 334 (98.2%) 1.00 (ref.) 0.01
Yes 10 (5.9%) 6 (1.8%) 3.74 (1.27–11.02)
Data were matched by age and gender, calculated by conditional logistic regression.
1Two-sided x
2 test or Fisher’s exact test for discrete variables and paired t-test for continuous variables.
doi:10.1371/journal.pone.0030951.t001
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cases were green tea nondrinkers (85.3% versus 66.5%; P,0.01).
Only a few cases (5.3%) consumed green tea more than ten years,
compared to 16.5% of controls (P,0.01). In addition, more cases
than controls were exposed to cooking fumes $1 hour per week
(20.6% versus 8.2%; P,0.01).
Table 2 shows the genotypic prevalence of IGF1 (CA)n repeat,
IGF2 820, IGFBP3 -202 among study subjects. Among subjects,
the number of repeats for the IGF1 (CA)n polymorphism ranged
13–25, and the most common allele was (CA)19 among both cases
and controls. The frequency for IGF1 (CA)19/(CA)19 and (CA)19/
X genotypes in cases was significantly lower than in controls
(51.8% versus 62.9%; P=0.02). The prevalence of IGF2 and
IGFBP3 genotypes in case and control groups was not significantly
different. Frequencies for the IGF1, IGF2, and IGFBP3 genotypes
were in Hardy-Weinberg equilibrium in the control group.
Further, we analyzed the association between green tea
consumption and lung cancer risk (Table 3). Subjects were
stratified into nonsmokers and smokers. The results showed a clear
association between green tea consumption and lung cancer risk in
current and ever smokers who drank less green tea (,1 cup per
day and never drank green tea, P for trend ,0.0001). After
adjusting for exposure to cooking fumes and family history of lung
cancer, we defined the smokers who drank $1 cup per day of
green tea as the reference group (OR=1.00). Compared with the
reference group, smokers who drank ,1 cup per day of green tea
had an OR of 13.32 (95% CI=2.79–63.61) for lung cancer;
smokers who never drank green tea had a 13.16-fold (95%
CI=2.96–58.51) greater risk of lung cancer. Smokers who never
drank green tea compared to smokers who drank green tea for
.10 years also had a significantly greater risk of lung cancer
(OR=3.34, 95% CI=1.41–7.93). A significant interaction
between smoking status and green tea consumption (number of
cups per day) on lung cancer risk was also observed.
Subsequently, we analyzed the joint effect of cumulative
smoking dose with IGF1, IGF2, and IGFBP3 genotypes on lung
cancer risk after adjusting for the effect of green tea consumption,
exposure to cooking fumes, and family history of lung cancer
(Table 4). Smoking status was stratified into 0, 1–39, $40 pack-
years smoked. We selected nonsmokers carrying the IGF1 (CA)19/
(CA)19 and (CA)19/X genotypes as the reference group
(OR=1.00). Nonsmokers carrying the IGF1 X/X genotype had
an OR of 1.29 (95% CI=0.78–2.15) for lung cancer. Among
those who smoked for 1–39 pack-years, those carrying the IGF1
(CA)19/(CA)19 and (CA)19/X genotypes (OR=3.78, 95%
CI=1.79–8.01) and IGF1 X/X genotype (OR=4.51, 95%
CI=1.99–10.22) had significantly increased risks of lung cancer.
Among those who smoked $40 pack-years, those carrying IGF1
Table 2. Genotype frequencies of IGF1 (CA)n repeat, IGF2 820 and IGFBP3 -202 among cases and controls.
Genotype Cases Controls OR (95% CI) P-value
1 P-value
2
(n=170) (n=340)
IGF1 (CA)n repeat (%)
(CA)19/(CA)19 23 (13.5%) 43 (12.6%) 1.00 (ref.) 0.03 0.20
(CA)19/X 65 (38.2%) 171 (50.3%) 0.71 (0.39–1.27)
X/X 82 (48.3%) 126 (37.1%) 1.23 (0.69–2.20)
(CA)19/(CA)19+(CA)19/X 88 (51.8%) 214 (62.9%) 1.00 (ref.) 0.02
X/X 82 (48.2%) 126 (37.1%) 1.61 (1.10–2.34)
(CA)19 allele 111 (32.6%) 257 (37.8%) 1.00 (ref.) 0.11
X allele 229 (67.4%) 423 (62.2%) 1.26 (0.96–1.66)
IGF2 820 (%)
GG 35 (20.6%) 85 (25.0%) 1.00 (ref.) 0.42 0.04
AG 75 (44.1%) 151 (44.4%) 1.17 (0.73–1.90)
AA 60 (35.3%) 104 (30.6%) 1.37 (0.83–2.25)
GG 35 (20.6%) 85 (25.0%) 1.00 (ref.) 0.27
AA+AG 135 (79.4%) 255 (75.0%) 1.26 (0.82–1.95)
G allele 145 (42.6%) 321 (47.2%) 1.00 (ref.) 0.17
A allele 195 (57.4%) 359 (52.8%) 0.84 (0.64–1.09)
IGFBP3 -202 (%)
CC 14 (8.2%) 36 (10.6%) 1.00 (ref.) 0.62 0.28
AC 66 (38.8%) 136 (40.0%) 1.25 (0.63–2.47)
AA 90 (53.0%) 168 (49.4%) 1.38 (0.71–2.70)
CC 14 (8.2%) 36 (10.6%) 1.00 (ref.) 0.40
AA+AC 156 (91.8%) 304 (89.4%) 1.32 (0.69–2.52)
C allele 94 (27.6%) 208 (30.6%) 1.00 (ref.) 0.33
A allele 246 (72.4%) 472 (69.4%) 1.16 (0.87–1.55)
Data were matched by age and gender, calculated by conditional logistic regression.
1Data were calculated by two-sided x
2 test.
2The probability of the x
2 test for Hardy-Weinberg equilibrium in control group.
doi:10.1371/journal.pone.0030951.t002
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CI=3.10–12.15) and IGF1 X/X genotype (OR=5.43, 95%
CI=2.84–10.36) also had significantly increased risk of lung
cancer. However, the test for interaction between cumulative
smoking dose and IGF1 genotypes on lung cancer risk was not
significant. Similar results also showed a significant combined
effect of cumulative smoking dose and IGF2 and IGFBP3
genotypes.
We also evaluated the effect of IGF1 (Table 5), IGF2, and
IGFBP3 (data not shown) on lung cancer risk by green tea
consumption. After adjusting for the effect of pack-years smoked,
exposure to cooking fumes, and family history of lung cancer, we
selected the IGF1 X/X genotype carriers as the reference group
for all green tea drinkers. Among green tea drinkers who drank $1
cup per day, IGF1 (CA)19/(CA)19 and (CA)19/X genotypes carriers
had a significantly reduced risk of lung cancer (OR=0.06, 95%
Table 3. Association between green tea consumption and smoking status with lung cancer risk.
Variable Smoking status
Never smokers Current and ever smokers
CA CN OR (95% CI) CA CN OR (95% CI)
Green tea consumption (cups/day)
$1 4 31 1.00 (ref.) 3 33 1.00 (ref.)
,1 3 38 0.69 (0.14–3.39) 15 12 13.32 (2.79–63.61)
1
0 71 179 1.95 (0.65–5.85) 74 47 13.16 (2.96–58.51)
1
P for trend 0.0025 ,0.0001
Test for interaction x
2=7.24 (2 df); P=0.03
Green tea consumption (years)
.10 2 29 1.00 (ref.) 7 27 1.00 (ref.)
#10 5 40 1.80 (0.33–9.75) 11 18 2.19 (0.76–6.28)
0 71 179 3.22 (0.76–13.58) 74 47 3.34 (1.41–7.93)
2
P for trend 0.0025 ,0.0001
Test for interaction x
2=0.13 (2 df); P=0.94
Data were matched by age and gender, calculated by multiple conditional logistic regression and adjusted for exposure to fume of cooking, and family history of lung
cancer.
1P,0.01,
2P=0.04; P value was adjusted by multiple testing (bonferroni correction).
doi:10.1371/journal.pone.0030951.t003
Table 4. The joint effect of cumulative smoking dose with IGF1 (CA)n repeat, IGF2 820, IGFBP3 -202 genotypes for lung cancer risk.
Variable Pack-years smoked
0 1–39 $40
CA CN OR (95% CI) CA CN OR (95% CI) CA CN OR (95% CI)
IGF1 (CA)n repeat genotypes
(CA)19/(CA)19+(CA)19/X 42 163 1.00 (ref.) 16 29 3.78 (1.79–8.01)
1 30 22 6.14 (3.10–12.15)
1
X/X 36 85 1.29 (0.78–2.15) 12 13 4.51 (1.99–10.22)
1 34 28 5.43 (2.84–10.36)
1
Test for interaction x
2=1.05 (2 df); P=0.59
IGF2 820 genotypes
GG 18 61 1.00 (ref.) 6 11 4.09 (1.34–12.54)
2 11 13 5.83 (2.28–14.93)
1
AA+AG 60 187 1.09 (0.58–2.06) 22 31 3.89 (1.71–8.83)
1 53 37 5.50 (2.55–11.89)
1
Test for interaction x
2=0.52 (2 df); P=0.77
IGFBP3 -202 genotypes
CC 6 27 1.00 (ref.) 1 4 2.05 (0.22–19.00) 7 5 4.71 (1.36–16.32)
2
AA+AC 72 221 1.16 (0.46–2.90) 27 38 4.43 (1.59–12.34)
3 57 45 6.13 (2.23–16.85)
1
Test for interaction x
2=0.79 (2 df); P=0.67
Data were matched by age and gender, calculated by multiple conditional logistic regression and adjusted for green tea consumption, exposure to fume of cooking,
and family history of lung cancer.
1P,0.01,
2P=0.08,
3P=0.03; P value was adjusted by multiple testing (bonferroni correction).
doi:10.1371/journal.pone.0030951.t004
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genotypes who drank green tea for .10 years had a significantly
reduced lung cancer risk (OR=0.34, 95% CI=0.12–0.95).
However, no significant decrease in risk of lung cancer was found
for green tea drinkers with IGF2 and IGFBP3 genotypes (data not
shown).
Discussion
Our study found a protective effect of green tea consumption on
lung cancer elicited by cigarette smoking. Green tea drinkers with
susceptible IGF1 (CA)19/(CA)19 and (CA)19/X genotypes had a
reduced risk of lung cancer.
Tea polyphenols may inhibit the induction of a variety of
cancers, including lung cancer [6,7]. Polyphenols appear to be
strong antioxidants and may also prevent mutagenicity and
genotoxicity, inhibit tumor initiation, promotion, and cell
proliferation, modulate detoxification enzymes, and trap activated
metabolites of carcinogens [6]. In different animal models, oolong
tea, jasmine tea, and green tea all inhibited lung tumorigenesis
induced by a variety of carcinogens, including nicotine-derived
nitrosamine ketone [6]. Our results suggest that individuals who
never drank green tea have an elevated lung cancer risk compared
to those who drank green tea at least one cup per day, and the
effect is more pronounced in smokers. However, epidemiological
studies of tea consumption and cancer are limited and the results
are inconclusive [8–10]. Although our finding of an inverse
association of green tea consumption with the risk of lung cancer is
consistent with previous experimental and epidemiological studies
[9,10], an alternative explanation for the observed association is
uncontrolled confounding factor.
The IGF1 (CA)19/(CA)19 genotype was reported previously to
correlate with lower serum level of IGF1 [18]. The IGF2 AA
genotype has been suggested to correlate with higher serum level
of IGF2 [19], and the IGFBP3 C allele to correlate with lower
plasma levels of IGFBP3 [20]. A previous study proposed that
higher IGF1 serum levels and lower IGFBP3 levels were associated
with cancer risk [15]; however, the intra-individual variability in
circulating IGF1, IGF2, and IGFBP3 levels is genetically
determined [18–20]. Thus, the association between IGF1, IGF2,
and IGFBP3 and cancer risk could be evaluated on the molecular
level. In our study, the frequency for IGF1 (CA)19/(CA)19 and
(CA)19/X genotypes in cases (38.2%) was significantly lower than
in controls (50.3%). Previous studies also have demonstrated a
protective effect of IGF1 (CA)19 allele on cancers, including breast,
prostate and colorectal cancers [24]. However, we did not observe
an independent relationship between the IGF2 and IGFBP3
polymorphisms and risk of lung cancer.
We investigated the joint effects of smoking and IGF1, IGF2,
and IGFBP3 genotypes on lung cancer, but no significant
interaction between cumulative smoking dose and IGF1, IGF2,
and IGFBP3 genotypes on lung cancer was observed. Several
studies have reported the association between smoking and IGF1
levels; however, results were inconsistent. A study by Kaklamani et
al. [14] showed a positive association between IGF1 levels and
pack-year history of smoking, but not with the number of
cigarettes currently smoked. A case control study by Yu et al.
[15] found no association between smoking status, pack-years of
smoking, number of years smoking, total number of cigarettes
currently smoked, and levels of IGF1 and IGFBP3 among control
subjects. Although the relationship of smoking and IGF level is
unclear, smoking may influence IGF physiology by influencing the
circulating levels of IGF. Regardless, heavy smoking in cumulative
dose would likely increase lung cancer risk by increasing
carcinogen exposure long-term, while simultaneously increasing
IGF1 or IGF2 levels or decreasing IGFBP3 levels. In keeping with
this speculation, we observed that heavy smokers with susceptible
IGF1, IGF2, and IGFBP3 genotypes had an elevated risk of lung
cancer, although the interaction effect was not significant (Table 4).
The possibility of an association between smoking, IGF1 level and
IGF1 genotype on lung cancer risk needs further investigation.
We also evaluated the effect of IGF1 on lung cancer risk by
green tea consumption. Interestingly, we observed that green tea
drinkers carrying IGF1 (CA)19/(CA)19 and (CA)19/X genotypes
had a significantly reduced risk of lung cancer compared with
those carrying the IGF1 X/X genotype. Individuals with IGF1
(CA)19/(CA)19 and (CA)19/X genotypes who drank more than one
cup of green tea per day also had significantly reduced lung cancer
risk. Experimental studies have shown that tea polyphenols
substantially reduce the levels of IGF1 in TRAMP mice [16] as
well as human colon cell lines [17]. Thus, tea polyphenols may
decrease lung cancer risk by lowering IGF1 levels [25]. Overall,
our results suggest that the inverse association of lung cancer risk
and green tea drinkers may be modulated by the IGFs system
consistent with experimental findings. The protective effect of
Table 5. Risk of lung cancer in association with IGF1 (CA)n repeat genotype by different status of green tea consumption.
Variable IGF1 X/X genotype IGF1 (CA)19/(CA)19+(CA)19/X genotypes
CA CN OR (95% CI) CA CN OR (95% CI)
Green tea consumption (cups/day)
0 68 86 1.00 (ref.) 77 140 1.34 (0.93–1.91)
,1 9 18 1.00 (ref.) 9 32 0.94 (0.44–2.02)
$1 5 22 1.00 (ref.) 2 42 0.06 (0.01–0.44)
1
Green tea consumption (years)
0 68 86 1.00 (ref.) 77 140 1.34 (0.93–1.91)
#10 11 16 1.00 (ref.) 5 42 0.34 (0.12–0.95)
2
.10 3 24 1.00 (ref.) 6 32 0.44 (0.19–1.03)
2
Data were matched by age and gender, calculated by multiple conditional logistic regression and adjusted for pack-years of smoking, exposure to fume of cooking, and
family history of lung cancer.
1P=0.03,
2P=0.11; P value was adjusted by multiple testing (bonferroni correction).
doi:10.1371/journal.pone.0030951.t005
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transcription activity of IGF1. However, our results should be
elucidated by larger studies.
The present study revealed that the (CA)19 allele frequency for
IGF1 is 37.8% in the Taiwanese population, similar to that in
other Asian populations (39.0%–40.8%) [26,27], but significantly
lower than in whites (64%–70.2%) [26,27]. The A allele frequency
for IGF2 is 52.8% in Taiwan, similar to the 50% seen in Korea
[28]; however, this is significantly higher than in Caucasian
population (28.0%) [29]. The A allele frequency for IGFBP3 is
more common in the Taiwanese (69.4%) and Japanese popula-
tions (75.2%) [30] than in the American populations (whites
40.9% and blacks 53.1%) [31]. All genotype distributions in our
healthy controls were in Hardy-Weinberg equilibrium. However,
IGF1, IGF2, and IGFBP3 may be susceptibility genes for lung
cancer only in certain ethnic populations.
In the current study, recall bias may be a potential problem.
Thus, misclassification of exposure may have influenced the effect
of cigarette smoking on lung cancer risk. In addition, although the
current study showed a protective effect of drinking green tea on
lung cancer, several other reasons may explain the inconsistency
between bioassays and the epidemiological data. First, quantifica-
tion of green tea consumption in epidemiological studies, including
this one, is subject to exposure misclassification that would tend to
obscure any association. In our study, consumption of green tea
was evaluated based on a previous study [10], in which spearman’s
coefficient for the correlation between the amounts of green tea
consumed according to the questionnaire and the amounts
consumed according to the three day in one year food records
was 0.66, and the correlation between consumption measured by
the two questionnaires administered six months apart was also
0.66. Since this may have resulted in non-differential misclassifi-
cation, it is likely that the current findings are underestimated.
Similar methods to assess green tea consumption have been
employed in other studies [32,33], implying the reasonable validity
of this assessment. Neither cases nor controls were aware of study
interest in green tea consumption. Thus, it is unlikely that
participants provided biases information on green tea. Second, the
concentrations of tea polyphenols used in the bioassays tend to be
much higher than those to which humans are exposed in their
routine consumption of green tea. Third, the bioavailability of
polyphenols from green tea consumption may be very limited,
since they are rapid metabolized and excreted. Several potential
biomarkers of exposure to tea polyphenols, such as 4-O-
methylgallic acid and isoferulic acid, have been proposed [34].
Unfortunately, no data was available on biomarkers for tea
polyphenol exposure in our study. In addition, previous epidemi-
ological studies may have obscured an association because the
chemopreventive effects of green tea may be limited to genetically
susceptible sub-populations. Our study was limited by the small
numbers of subjects might generate a false positive result,
especially in the analysis of subgroup. A larger study that includes
a sufficient number of participants has the potential to show dose-
effect relationships. Among 170 patients available for matching,
the frequency of major cell types (adenocarcinoma, 54.7%;
squamous cell carcinoma, 27.1%) was similar to that reported in
a previous study conducted in Taiwan [35]. The male-to-female
ratio of lung cancer in Taiwanese is approximately at 2:1 [35]. In
our present study, the proportion of males with lung cancer was
60%, which was close to general population in Taiwan. The mean
age of our lung cancer patients at recruitment was 66.2 years was
also comparable to that found in a previous study for Taiwanese
(63.4 years) [35]. In addition, prevalence of cigarette smoking in
our study subjects (cases, 54.1%; controls, 27.1%) was consistent
with the findings of a previous study in Taiwanese (cases, 52.4%;
controls, 29.9%) [36]. Therefore, our study subjects could be
regarded to as representative of the general population of Taiwan.
However, selection bias could have occurred when the healthy
persons for physical check-up may have healthier behavior were
enrolled as our study subjects.
Our study suggests an protective effect of green tea on lung
cancer elicited by cigarette smoking. Green tea drinkers with
susceptible IGF1 genotypes have a reduced risk of lung cancer.
Heavy smokers carrying susceptible IGF1, IGF2, and IGFBP3 have
a higher risk of lung cancer. This result may indicate that smoking-
induced pulmonary carcinogenesis may be modulated by green tea
consumption and the growth factor environment.
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